Allied Academies Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies. This publishing house has been built on the base of esteemed academic and research institutions including, The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP).
Opioid 2018 is all about providing a resourceful and knowledgeable arena for the participants in the field of Opioid Addiction. We strive to provide a perfect stage to share knowledge and experiences and encourage people to carry out effective researches and works to combat against the global threat. We have research expertise and psychiatrists from different parts of the world coming to share their latest research works in the field of opioid and to inspire the young minds we are glad to present a special category - The Young Researcher Forum (YRF).
Physicians, Nurses, Pharmacists, Dentists, Psychiatrists,
Advocates, Families, and People in Recovery
Law Enforcement Personnel
Public Health and Prevention Officials
Federal, state, and local officials and Lawmakers
Education Specialists and Researchers
Treatment center owners and Operators
Lawyers, Judges, and Drug court Officials
Clinicians, Counselors, Social workers, Therapists, Psychologists, Interventionists
Why should you attend?
According to the U.S. Centers for Disease Control, as the clinical use of Opioid has risen over the past two decades, Opioid associated harm has risen in parallel. We must find a balance in the use of these powerful medications that supports their valuable role in healing while avoiding harm. This intensive 2+ day program led by renowned specialists is designed to inform Primary care Physicians, Pain Specialists, Pharmacists and others with new data and essential information in the best practices, abuses and legal ramifications of Opioid Addiction.
The conference features a full schedule of topics and speakers who will address all aspects of the medical use of Opioid. Participate in constructive panel discussions and case studies with leaders in Opioid pain management. Take advantage of meeting leaders and networking with colleagues.
Allied Academies is pleased to welcome the enthusiasts from all over the world to " Annual Summit on Opioids, abuse and addiction " at Chicago, USA to be held on December 7-8, 2018. Opioid 2018 welcomes primary care Physicians, Pain Specialists, Research Scholars, Faculty members, Law Enforcement Personnel, Young Examiners and Psychiatrists, Doctors, Professors, and Students from around the globe to make the social affair a perfect stage to dole out and get encounter, propel joint endeavors across over pharma industry and educational world.
Allied Academies Organizes Opioid 2018 along with 300+ Conferences across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities as editorial board members.
Track: -1 Opioid and Opioid Pharmacology
Opioids have similar characteristics as that of opium. The main role of opioids is to produce sedation and pain relief. Opioids are the chemicals which that attach to opioids receptors present in the gastrointestinal tract and brain central nervous system to stimulate their upshots. Opioids bind to opioid receptors in the nervous system and other tissues. There are three principal categories of opioid receptors (mu, kappa, and delta).
b. Signal Transduction
c. Functional Selectivity
Track: -2 Opioid Formulations and Delivery System
Many new drugs formulation and delivery system have been reinforced that may help further individualize analgesic regimens for those patients with chronic pain. Pain management psychotherapies were primarily limited to short-acting opioid formulations or only those opioids with inherently longer duration of action. The development of technologies that can sway the release and slow absorption of a drug to provide an extended duration of action has led to significant potential benefits for patients with chronic pain. Tamper-resistance formulations could potentially contribute to the reduction of the abuse and misuse of opioids.
a. Fentanyl Formulations
b. Morphine Formulations
c. Oxycodone Formulations
Track:-3 Administration of Opioids
The major pharmacological treatment for acute pain persists to be opioids. Traditional methods of opioid direction are oral, intramuscular, subcutaneous and intravenous. Acute pain management has ameliorated with the introduction of developed techniques for administration of opioids (patient controlled analgesia [PCA] and epidural analgesia). Oral opioids are available as immediate-release (IR) and slow-release (SR) and can be used as step-down analgesia from epidurals or PCAs. Oral morphine has a bioavailability of about 30%--10 mg of IV morphine is roughly equivalent to 30mg of oral morphine.
a. Traditional Methods
b. Opioid-sparing Method
Track: - 4 Opiate Epidemic / Opioid Crisis
The Opioid epidemic or Opioid crisis is the rapid expand in the use of prescription and non-prescription opioids in the United States and Canada in the 2010. Opiates are strong painkillers or analgesic drugs. In 2016, deaths from overdoses increased over the previous year by 26% in Connecticut, 35% in Delaware, 39% in Maine, and 62% in Maryland. In 2015, 52,000 Americans died from drug overdoses, and in 2016 the numbers increased another 19 percent, to approximately 62,000.
a. Prescription Opioid
b. Non-Prescription Opioid
c. Over Dose
d. Economic Impact of the Opioid
Track: - 5 Pain Management
Pain management medications alter the insight of pain by reducing the potency of pain signals sent to the brain. Long-term use of opioids as a pain management medication may cause complexions, such as tolerance to the effects of the drug or addiction. It is cautiously planned and closely monitored by a pain medication specialist as a part of an integrated approach to controlling pain. Opioids may not interact well when taken along with other pain management medications.
a. Acute Surgical Pain
b. Chronic non-malignant Pain
c. Comprehensive Opioid Management
d. Use of Opioids in Cancer Survivors
Track: - 6 Opiate Abuse and Addiction
Opioids are a class of impactful drugs that are essentially prescribed to treat acute pain. If opioids are abused, they can create tenderness of intense pleasure or euphoria, and can also lead to fatal overdose, along with other medical, legal and social problems. Opioids include felonious drugs, such as heroin, as well as prescription medications, such as Percocet, morphine and codeine. Opioids are powerful medication when used as prescribed, but they carry a risk of addiction because of their powerful effects. Opioid addiction involves more than just physical dependence.
a. Addiction and Bipolar Disorder
b. Risks for opioid Addiction
c. Neurobiology of Addiction
d. Behavioral Addictions
e. Adolescent Opioid Addiction
f. Drug Abusers
g. Youth Drug Abuse
Track: - 7 Opioid Rotation
Opioid rotation refers to a shift from one opioid to another to ameliorate the response to analgesic therapy or reduce adverse effects. It is a common method to address the trouble of poor opioid responsiveness regardless of optimal dose titration. Opioid rotation or opioid switching is a convention used in the management of severe chronic pain.
a. Induced Hyperalgesia
c. Practice is evolving with respect to Opioid Rotation.
d. Reasons for Rotation/Conversion
Track: - 8 Behavioral health
The current study link has been found between those troubled by mental state disorders and the future use of opioid medicine. The study, featured in a magazine called “Pain” reported that those that suffered from, or who were diagnosed with some type of mental health issue were more susceptible to developing a long-term abuse problem with opioid drugs later in life.
a. Psychosocial Interventions
b. Behavioral Science
c. Relapse Prevention
d. Group and Family Therapy
e. Behavioral Marital Therapy
Track: - 9 Use of Opioids in Chronic Non-Cancer Patients
Opioids are recommended in various guidelines for chronic non-cancer pain because evidence of long term benefit is weak. Opioids have a place in the management of chronic non-cancer pain in carefully selected patients with regular monitoring and as a part of the multimodal therapy. Chronic non-cancer pain including neuropathic pain, case series and randomized controlled trials demonstrates high quality evidence for a weak recommendation for opioids when used in the short term.
A. Opioid- induced Disorder
B. Opioid- induced Mental Disorder
C. Psychological Dependence
Buprenorphine is a mixed partial agonist opioid receptor modulator. It is the partial agonist properties of buprenorphine that make it a safe and an effective option for the treatment of opioid addiction. The combination buprenorphine/naloxone is also used for opioid addiction. It is a mixed partial agonist opioid receptor modulator. Buprenorphine is a novel and attractive medication option for many opioid-addicted adults and their physicians.
a. Maintenance Treatment of Buprenorphine Drug
b. Sign and Symptoms of Buprenorphinec. Buprenorphine Pharmacology
Track: - 11 Medical Marijuana and Opioids
Twenty-five states and the District of Columbia, have passed laws since 1996 legalizing the use of medical marijuana for qualifying patients under state law. Medical marijuana programs differ from one another in significant ways, most allow medical marijuana for the treatment of severe, intractable pain. Marijuana’s medical safety and potency are well supported – especially for the treatment of various types of severe and chronic pain.
a. Safety and Efficacy of Medical Marijuana
b. Uses of Marijuana and Opioid
c. Sign and symptoms of Medical Marijuana and Opioids
Track: - 12 Opioid Overdose Prevention
Opioids are used as medicines to cure pain and opioid dependence. If used in excess or without proper medical supervision, opioids can cause fatal respiratory depression. In cases of fatal overdose, the victim’s breathing rate slows to the point where oxygen levels in the blood fall below the level needed to transfer oxygen to the vital organs. As oxygen saturation (normally greater than 97 per cent) falls below 86 per cent, the brain struggles to function. Typically, the individual becomes unresponsive, blood pressure steadily decreases and the heart rate slows, ultimately leading to cardiac arrest. Death can occur within minutes of opioid ingestion. But often, prior to death there is a longer period of unresponsiveness lasting up to several hours. This period is sometimes associated with loud snoring, leading to the term “unarousable snorers”.
b. Naloxone Intervention
c. Prescription Monitoring Program
d. Best Practices in Opioid Prescription
Track: - 13 Cognitive Behavior Therapy
Cognitive behavioral therapy (CBT) is a psychosocial intervention that is the most widely used evidence-based custom for improving mental health. CBT focuses on the development of personal coping strategies that target solving current trouble and changing unhelpful patterns in cognitions (e.g. thoughts, beliefs, and attitudes), behaviors, and emotional regulation. The CBT model is based on association of the basic principles from behavioral and cognitive psychology.
a. Interpersonal Psychotherapy
b. Cognitive Emotional Behavioral Therapy
c. Moral Reconation Therapy
Track: - 14 Opiate Dependence Treatment
The progress of effective treatments for opioid dependence is of great importance given the ruinous consequences of the disease. Pharmacotherapies for opioid addiction include opioid agonists, partial agonists, opioid antagonists, and alpha-2-adrenergic agonists, which are earmark toward either detoxification or long-term agonist maintenance. Agonist maintenance therapy is currently the endorsed treatment for opioid dependence due to its superior outcomes relative to detoxification.
a. Medication-Assisted Treatment(MAT)
c. Improving the Treatment of Pain
Track: - 16 Law Enforcement Resources
Law enforcement is an organization by which some members of society act in a methodical manner to implement the law by discovering, dissuade, rehabilitating, or punishing people who contravene the rules and norms governing that society. Law enforcement may be most concerned with the prevention and punishment of felony, organizations exist to demoralize a wide variety of non-criminal violations of rules and norms, effected through the imposition of less severe consequences.
a. Drug and Chemical Information
b. Law Enforcement Naloxone Toolkit
c. Prescription Drug Fraud and Misuse
d. Mental Health and substance use disorder parity rule for Medicaid and CHIP
e. Drug Enforcement Administration
Track: - 17 Current Topics on Opioid REMS
FDA initiated a risk appraisal and mitigation strategy (REMS) for extended-release and long-acting (ER/LA) opioids that required companies marketing ER/LA opioids to provide a medication direct and make teaching available to prescribers. The training must be provided by accredited providers and cover all elements of the agency's Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics.
a. FDA Issues Guidance on REMS
b. Drug Safety and Risk Management Advisory Committee
c. Anesthetic and Analgesic Drug Products Advisory Committee
Track: - 18 Federal and State Regulation of Opioids
Federal and state policy governing opioids is considered to achieve balance between efforts to control drug abuse and maintain drug availability for legitimate medical purposes. Federal law declares the essential medical value of many drugs that are controlled substances, and states that opioids may be used for extended periods in treatment of patients with uncontrollable pain. Physicians should report opioid-dependent patients to the government, regulate prescribing of Schedule II opioids more strictly, and limit the quantity of controlled substances that may be prescribed at one time. Recommendations are offered to revise state laws and to improve communication between health care professionals and regulators.
Psychology is the science of behavior and mind, embracing all aspects of conscious and unconscious experience as well as thought. Psychologists explore behavior and mental processes, including perception, cognition, attention, emotion (affect), intelligence, phenomenology, motivation (conation), brain functioning, and personality.
a. Social Psychology
b. Behavioral Psychology
c. Cognitive Psychologyd. Neuro Psychology
e. Biological Psychology
Opioids play a unique role in our new generation society.These are the widely feared compounds, which are associated with the awful corollary of diversion, these are also essential medications, the most potent drugs for the relief of pain and suffering.
There is tremendous growth for the pain management therapies in the market due to growing of geriatric population prone to irremediable; and irrevocable conditions. The opioidal market in North America has valued USD 12.4 billion in 2015 and is assumed to rise at a CAGR of 4.6% over the prognosticate period.
A high incidence of abuse attached to the use of opioidal medication is an important factor moving its sale output. In addition, other factors including the rising insight of generics coupled with the growing healthcare expenditure levels in the North America region is supposed to provide a profitable growth platform to this sector over the forecast period. The increase in the number of palliative care centers and home healthcare services is also expected to propel the demand for these drugs.
Pain relief medicines are being dominated by the non-opioid, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) since they do not have the risk of developing drug dependency. However, NSAIDs is not effective in relieve of pain when used over a long period of time as these drugs are usually characterized by a ceiling effect.
The extended-release (ER)/long-acting opioids have dominated the overall market in 2015 with a revenue of 55.07% with those of other market available drugs and are expected to increase more at the highest CAGR of 6.5% over the forecast period.
Applications involved in opioid management are pain relief, cough suppression, anesthesia, diarrhea suppression, and de-addiction. The pain relief category has dominated the application segment with a revenue generation of over USD 8.3 billion in 2015. Anesthesia, on the other hand, is estimated to grow at a lucrative growth rate of 5.4% till 2024.
The cancer pain segment bears the largest share of the pain relief segment. The presence of cancer pain specific drugs, such as OxyContin, coupled with the burgeoning incidence rates of cancer are factors contributing towards the large market share.
The U.S. influenced the North America Opioid Market with a revenue share of 95.7% in 2015. The dominance of the country is mainly attributed to the escalating elderly population with a higher prevalence of chronic conditions.
Despite the strict regulations enforced by the government for controlling opiate drug abuse, the prescription sales of these drugs have been experiencing a steep growth in the past few years. However, the ban levied on the sales of the opioid-containing OTC products in the region is hampering the growth of the vertical.
Major associations supporting opioids are
American Association for the Treatment of Opioid Dependence (AATOD)
American College of Clinical Pharmacology (ACCP)
American College of Psychiatrists (ACP)
American Medical Association (AMA)
American Mental Health Counselors Association (AMHCA)
American Psychiatric Association (APA)
American Public Health Association (APHA)
California Opioid Maintenance Providers (COMP)
Colorado Organization for the Treatment of Opioid Dependence (COTOD)
Mental Health America
National Alliance on Mental Illness (NAMI)
National Association of Addiction Treatment Providers (NAATP)
National Alliance of Advocates for Buprenorphine Treatment (NAABT)
Opioid Treatment Providers of Georgia (OTPGA)